CompletedPhase 1Phase 2

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

NCT01111825

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Western Regional Medical Center, Inc.

Goodyear, Arizona, United States

+11 additional locations

Save this trial

Western Regional Medical Center, Inc.Goodyear, Arizona, United States
USC/Norris Comprehensive Cancer CenterLos Angeles, California, United States
Memorial Sloan Kettering Cancer Center (MSKCC)New York, New York, United States
Weill Cornell Medical College - New York - Presbyterian HospitalNew York, New York, United States
Roskilde HospitalRoskilde, Denmark
Institut Gustave RoussyVillejuif, France
UNIMED Medical InstituteWan Chai, Hong Kong
Hospital Universitario Sant Joan de ReusTarragona, Reus, Spain
Hospital Universitario Vall d'HebronBarcelona, Spain
Hospital Universitari Arnau de Vilanova de LleidaLleida, Spain
Edinburgh Cancer Center, Western General HospitalEdinburgh, United Kingdom
The Royal Marsden NHS Foundation TrustLondon, United Kingdom